Risk factors for osteoporosis in a subgroup of elderly men in a Veterans Administration nursing home

Journal of Investigative Medicine

Volumn 50, Issue 6, 2002, Pages 452-457

  Yeh, Shing Shing ^a   Phanumas, Donna ^a   Hafner, Alice ^a   Schuster, Michael W ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antipsychotic agent; Body weight; Chronic obstructive; Hypogonadism; Osteoporosis; Pulmonary disease

Indexed keywords

CORTICOSTEROID; FOLLITROPIN; HALOPERIDOL; LUTEINIZING HORMONE; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PROLACTIN; RISPERIDONE; TESTOSTERONE;

AGED; ANAMNESIS; ARTICLE; BONE MINERAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DEMENTIA; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; HUMAN; HYPOGONADISM; MALE; MEDICAL RECORD; MORBIDITY; NURSING HOME; OSTEOPOROSIS; RISK FACTOR; SCHIZOPHRENIA; SMOKING; UNDERWEIGHT; ADULT; BIPOLAR DISORDER; BODY WEIGHT; BONE DENSITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FALL RISK; GOVERNMENT; INCIDENCE; MEDICAL HISTORY; MENTAL PATIENT; NURSING HOME PATIENT; PARKINSON DISEASE;

EID: 0036841332     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-50-06-05     Document Type: Article

References (26)

1. Seeman E, Melton LJ III, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977-983.
2. Lau E, Donnan S, Barker DJ, Cooper C. Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ 1988;297:1441-1443.
3. Coin A, Sergi G, Beninca P, Lupoli L, Cinti G, Ferrara L, Benedetti G, Tomasi G, Pisent C, Enzi G. Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int 2000;11:1043-1050.
4. Dickson RA, Glazer WM. Neuroleptic-induced hyperprolactinemia. Schizophr Res 1999;35(Suppl):S75-S86.
5. Petty RG. Prolactin and antipsychotic medications: Mechanism of action. Schizophr Res 1999;35(Suppl):S67-S73.
6. Rogers GA, Burke GV. Neuroleptics, prolactin, and osteoporosis. Am J Psychiatry 1987;144:388-389.
7. Ataya K, Mercado A, Kartaginer J, Abbasi A, Moghissi KS. Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil Steril 1988;50:876-881.
8. Kartaginer J, Ataya K, Mercado A, Abbasi A. Osteoporosis associated with neuroleptic treatment: A case report. J Reprod Med 1990;35:198-202.
9. Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, Rosan R. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995;57:485-491.
10. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39:766-771.
11. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990;150:2545-2548.
12. Praet JP, Peretz A, Rozenberg S, Famaey JP, Bourdoux P. Risk of osteoporosis in men with chronic bronchitis. Osteoporos Int 1992;2:257-261.
13. Bikle DD. Biochemical markers in the assessment of bone disease. Am J Med 1997;103:427-436.
14. McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM, Niewoehner DE. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:704-709.
15. Nishimura Y, Nakata H, Matsubara M, Maeda H, Yokoyama H. Bone mineral loss in patients with chronic obstructive pulmonary disease [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:1548-1552.
16. Riancho JA, Gonzalez Macias J, Del Arco C, Amado JA, Freijanes J, Anton MA. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 1987;42:962-966.
17. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-269.
18. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999;159:941-955.
19. Wisniewski AF, Lewis SA, Green DJ, Maslanka W, Burrell H, Tattersfield AE. Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. Thorax 1997;52:853-860.
20. Luengo M, del Rio L, Pons F, Picado C. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: A case-control study. Eur Respir J 1997;10:2110-2113.
21. Toogood JH, Baskerville JC, Markov AE, Hodsman AB, Fraher LJ, Jennings B, Haddad RG, Drost D. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol 1995;96:157-166.
22. Ip M, Lam K, Yam L; Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105:1722-1727.
23. Devogelaer JP, De Cooman S, Nagant de Deuxchaisnes C. Low bone mass in hypogonadal males: Effect of testosterone substitution therapy-A densitometric study. Maturitas 1992;15:17-23.
24. Morley JE, Perry HM III, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM Jr. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study. J Am Geriatr Soc 1993;41:149-152.
25. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI. Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-4365.
26. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386-2390.